Intellectual Property

Global IP Infringement’s Significant Cost to the U.S. Economy

February 26, 2015
| Blogs & Op-eds

International infringement of U.S. intellectual property, including through counterfeiting, piracy, and outright IP theft, continues to take a significant toll on the U.S. economy.

IP Protection: Access To Medicine Is Important But So Is Its Continued Improvement

February 17, 2015
| Blogs & Op-eds

A recent op-ed by Joseph Stiglitz wrongly paints efforts to protect medical intellectual property (IP) as a grand conspiracy by drug companies. In fact, IP rights are a central tool for protecting the global innovation ecosystem and insuring that next generation medications and treatments make it to market.

You’re Ruining It for the Rest of Us: Ecuador and Intellectual Property

February 13, 2015
| Blogs & Op-eds

The IP environment in Ecuador, especially with regard to pharmaceuticals and biologics is shameful. And it is just one of a long line of countries doing so around the world, which risks perpetuating a global contagion effect.

Advertisers Take Big Step Forward to Reduce Facilitating Piracy

February 11, 2015
| Blogs & Op-eds

The Trustworthy Accountability Group (TAG) is creating a program to stop advertisers from placing advertisements on websites with unlicensed content or those offering counterfeit goods. This program shows that good faith stakeholders can and should come together to curb bad online activity, like the theft of copyrighted works, while creating jobs and incentivizing investment, innovation, and creativity.

Obama, Goodlatte Seek Balance on CFAA Cybersecurity

U.S. News and World Report
“If you engage in piracy and it is intentional, there ought to be a penalty,” says Robert Atkinson.

Can Competition Hurt Innovation?

January 8, 2015
| Blogs & Op-eds

We need to ensure that pharmaceutical companies that invest smartly in new research are able to survive not by getting lucky but by having a diversified drug portfolio and sufficient continued revenue from past successes. By driving down profits, competition can decrease innovation by diminishing potential rewards. Policymakers should be wary of adverse side effects when sacrificing pharmaceutical profits for consumer welfare.

IPRs and Access to Medicines: New Evidence

January 7, 2015
| Blogs & Op-eds

Those in the global health community often allege that prices of new innovative drugs under patent make them unaffordable to most people in developing countries because of the absence of generic competition. A new report, however, finds good news about the relationship between IPRs and access to innovative medicines.

Piracy is Unstoppable (Like MySpace)

December 12, 2014
| Blogs & Op-eds

On Wednesday, a blogger at the Washington Post wrote a piece alleging that the removal of Pirate Bay from the Internet will do nothing to stem the rise of online piracy.

Landmark Trade Deal at Risk without Strong Intellectual Property Laws

November 14, 2014
| Blogs & Op-eds

The ambitious goal of creating a next-generation trade agreement through the completion of the Trans-Pacific Partnership, which aligns America with 11 of its trading partners across the Pacific region, is at risk of failing if negotiators cave in to pressures to strip it of strong intellectual property protections.

Newsflash: You Don't Have to Pirate Content

November 12, 2014
| Blogs & Op-eds

Wheretowatch.com is a simple way for consumers to legally find all the movies and television they are interested in viewing — from new episodes of TV to classic movies to even films still in theaters.

Syndicate content